CS162715B2 - - Google Patents
Info
- Publication number
- CS162715B2 CS162715B2 CS2509A CS250970A CS162715B2 CS 162715 B2 CS162715 B2 CS 162715B2 CS 2509 A CS2509 A CS 2509A CS 250970 A CS250970 A CS 250970A CS 162715 B2 CS162715 B2 CS 162715B2
- Authority
- CS
- Czechoslovakia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19691919570 DE1919570B1 (de) | 1969-04-17 | 1969-04-17 | Isochinolinderivate |
| DE19702000339 DE2000339C3 (de) | 1970-01-05 | 1970-01-05 | Isochinolinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS162715B2 true CS162715B2 (cs) | 1975-07-15 |
Family
ID=25757278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS2509A CS162715B2 (cs) | 1969-04-17 | 1970-04-14 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3708486A (cs) |
| BE (1) | BE748948A (cs) |
| BG (1) | BG17778A3 (cs) |
| CS (1) | CS162715B2 (cs) |
| ES (1) | ES378672A1 (cs) |
| FR (1) | FR2042341B1 (cs) |
| GB (1) | GB1277847A (cs) |
| IE (1) | IE34096B1 (cs) |
| IL (1) | IL34328A (cs) |
| IT (1) | IT7949558A0 (cs) |
| MY (1) | MY7500210A (cs) |
| NL (1) | NL146492B (cs) |
| RO (1) | RO55588A (cs) |
| YU (1) | YU34036B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES398959A1 (es) * | 1971-01-23 | 1975-09-16 | Hoechst Ag | Procedimiento para la preparacion de bencenosulfonilureas. |
| DE2734222A1 (de) * | 1977-07-29 | 1979-02-15 | Thomae Gmbh Dr K | Neue schwefelhaltige isochinolindione |
| DE3320583A1 (de) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung |
| US8268352B2 (en) * | 2002-08-05 | 2012-09-18 | Torrent Pharmaceuticals Limited | Modified release composition for highly soluble drugs |
| US8216609B2 (en) * | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
| BRPI0809583B1 (pt) * | 2007-03-30 | 2022-02-22 | Ambrx, Inc | Polipeptídeo fgf-21 modificado, composição compreendendo o mesmo, método para produzir o referido polipetídeo fgf-21 e célula compreendendo um polinucleotídeo |
| UY36370A (es) | 2014-10-24 | 2016-04-29 | Bristol Myers Squibb Company Una Corporación Del Estado De Delaware | Polipéptidos fgf-21 modificados y sus usos |
-
1970
- 1970-04-06 US US00026072A patent/US3708486A/en not_active Expired - Lifetime
- 1970-04-07 BG BG14436A patent/BG17778A3/xx unknown
- 1970-04-08 YU YU914/70A patent/YU34036B/xx unknown
- 1970-04-11 RO RO63059A patent/RO55588A/ro unknown
- 1970-04-14 BE BE748948D patent/BE748948A/xx not_active IP Right Cessation
- 1970-04-14 CS CS2509A patent/CS162715B2/cs unknown
- 1970-04-16 IL IL34328A patent/IL34328A/xx unknown
- 1970-04-16 ES ES378672A patent/ES378672A1/es not_active Expired
- 1970-04-16 IE IE486/70A patent/IE34096B1/xx unknown
- 1970-04-16 GB GB08242/70A patent/GB1277847A/en not_active Expired
- 1970-04-17 NL NL707005549A patent/NL146492B/xx not_active IP Right Cessation
- 1970-04-17 FR FR7014060A patent/FR2042341B1/fr not_active Expired
-
1975
- 1975-12-30 MY MY210/75A patent/MY7500210A/xx unknown
-
1979
- 1979-06-27 IT IT7949558A patent/IT7949558A0/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU91470A (en) | 1978-05-15 |
| IE34096L (en) | 1970-10-17 |
| GB1277847A (en) | 1972-06-14 |
| IL34328A (en) | 1973-05-31 |
| BG17778A3 (cs) | 1973-12-25 |
| YU34036B (en) | 1978-10-31 |
| US3708486A (en) | 1973-01-02 |
| MY7500210A (en) | 1975-12-31 |
| NL7005549A (cs) | 1970-10-20 |
| FR2042341A1 (cs) | 1971-02-12 |
| IL34328A0 (en) | 1970-06-17 |
| ES378672A1 (es) | 1975-06-01 |
| RO55588A (cs) | 1974-02-01 |
| IT7949558A0 (it) | 1979-06-27 |
| IE34096B1 (en) | 1975-02-05 |
| BE748948A (fr) | 1970-10-14 |
| FR2042341B1 (cs) | 1974-05-24 |
| NL146492B (nl) | 1975-07-15 |